Goodwin Presents on Practical Considerations for Foreign Developers Launching a Biosimilar in the US at JP Morgan Healthcare Conference

Goodwin and the Big Molecule Watch team are looking forward to participating in the 37th Annual JP Morgan Healthcare Conference, bringing together industry leaders from across the country. If you are at the conference in San Francisco, we hope you will join the team today, January 9, 2019 for our annual biosimilars seminar where Goodwin partners and Big Molecule Watch editors will lead a discussion on practical considerations for foreign developers launching a biosimilar in the US. For more information please click here.

Download PDF